JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,671 | +85.6% | 3,606 | +11.3% | 0.00% | – |
| Q4 2022 | $3,595 | +259.5% | 3,239 | +944.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 310 | +384.4% | 0.00% | – |
| Q3 2020 | $1,000 | -99.6% | 64 | -99.8% | 0.00% | -100.0% |
| Q2 2020 | $278,000 | +18.3% | 40,271 | -18.7% | 0.00% | 0.0% |
| Q1 2020 | $235,000 | +840.0% | 49,555 | +1607.6% | 0.00% | – |
| Q4 2019 | $25,000 | +1150.0% | 2,902 | +701.7% | 0.00% | – |
| Q2 2019 | $2,000 | -90.0% | 362 | -88.6% | 0.00% | – |
| Q1 2019 | $20,000 | -23.1% | 3,180 | -59.0% | 0.00% | – |
| Q4 2018 | $26,000 | +100.0% | 7,754 | +289.6% | 0.00% | – |
| Q3 2018 | $13,000 | +550.0% | 1,990 | +736.1% | 0.00% | – |
| Q2 2018 | $2,000 | – | 238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |